800384

GSK LLC (GlaxoSmithKline) — FEI 3006810568

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 19, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Collegeville, PA (United States)

Additional Details

Risk Evaluation and Mitigation Strategies (REMS)